Global Connected Drug Delivery Devices Market (2018-2025)-GMI Research

1. Global Connected Drug Delivery Devices Market (2018-2025)-GMI Research Posted by Sarah Nash November 26, 2018 in Healthcare Global Connected Drug Delivery Devices Market by Product Type (Inhalation Devices, Solid Dosage Forms Devices and Injectable Devices), By Technology (Bluetooth, Near Field Communication and Others), By End-Users (Hospitals, Ambulatory Surgical Centers and Homecare Settings) and by Geography – Opportunities & Forecast, 2018-2025 Connected drug delivery devices are widely used among healthcare professionals as well as patients. Connected drug delivery devices are designed in a way to accomplish a multifunctional task as it helps to record and remind dossing pattern, addressing the issues related to the medication management, etc. Connected drug delivery devices are basically user-friendly, patient-centric, quick and efficient, easily accessible. The deployment of connected drug delivery devices is gaining traction across the globe.

2. Request Sample Pages : https://tinyurl.com/y8wreuwc Factors such as the growing incidence of chronic disease, increasing geriatric population and rising preference for connected injectable drug delivery are driving the growth of global connected drug delivery device market during the forecast period. In addition, cloud-based computing models, the proliferation of mobile health application, introduction of the monitoring device and advancement in healthcare IT are leading the healthcare industry towards the new era. Moreover, increase use of self-administration of drugs through connected drug delivery device and penetration of artificial intelligence technology and big data analytics, especially for real-time decision making to manage medication is expected to fuel the growth of the market. One of the key challenges for widespread adoption in connected drug delivery applications remains the integration of electronic communications systems into the devices. However, cost containment, inadequate reimbursement policies in emerging countries and lack of awareness among patient regarding the latest technology are the major factors that are restraining the growth of global connected drug delivery devices market over the coming few years. Various notable players operating in the market, include Phillips-Medisize, West Pharmaceutical Service, Biocorp Production SA, Aterica, Unilife Corporation, Panasonic, Propeller Health, Qualcomm Technologies, Bayer AG, 3M Company among others. Most of the pharmaceutical company are focusing on strategic collaboration with tech firms to design and developed innovative product. For instance, Propeller Health entered into a strategic partnership with Express Scripts to provide digital solutions to Express Script members. The global connected drug delivery devices market has been segmented on the basis of product type, technology, end-users, and key geographies. Based on product type, the market comprises of inhalation devices, solid dosage forms devices and injectable device. The research report “global connected drug delivery devices market” provides in-depth analysis of global connected

3. drug delivery devices market based on product type, technology, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global connected drug delivery devices market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market. Key questions answered in this research report: 1- At what pace is connected drug delivery devices market growing? What will be growth trend in future? 2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future? 3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the connected drug delivery devices market? 4- What are the various application areas and how they are poised to grow? Market Segmentation By Product Type • Inhalation Devices • Solid Dosage Forms Devices • Injectable Devices o Handheld Injectable Devices o Wearable Injectable Devices By Technology • Bluetooth • Near Field Communication • Others By End-Users • Hospitals • Ambulatory Surgical Centers • Homecare Settings

4. By Geography • North America As a part of customization o By Product Type o By Technology o By End users o US o Canada o Mexico • Europe As a part of customization o By Product Type o By Technology o By End users o UK o Germany o Spain o Rest of Europe • Asia-Pacific As a part of customization o By Product Type o By Technology o By End users o China o Australia o India o Rest of APAC • ROW As a part of customization o By Product Type o By Technology o By End users

5. o Brazil o South Africa o GCC countries o Rest of world (remaining countries of the LAMEA region) Leading market players • Phillips-Medisize; • West Pharmaceutical Service • Biocorp Production SA • Aterica • Unilife Corporation • Panasonic • Propeller Health • Qualcomm Technologies • Bayer AG • 3M Company *Other prominent players in the market which can be profiled as a part of customization: CeQurSA CareTRx CoheroHealth Teva Pharmaceutical Industries Ltd For Sample Pages & Detailed Report Description Visit :https://www.gmiresearch.com/report/global-connected-drug-delivery-devices- market-opportunities-forecast-iot-share-trends-insights.html Table of Contents (TOC) 1. Executive Summary 2. Introduction 2.1. Study Objectives 2.2. Market Definition 2.2.1. Market Covered 2.2.2. Geographical Coverage

6. 2.2.3. Study Years & Currency 2.3. Market Stakeholders 2.4. Key Questions this Study will Answer 2.5. GMI Research’s Approach & Methodology 3. Global Connected Drug Delivery Devices Market – Overview 3.1. Introduction ` 3.2. Market Segmentation 3.3. Value Chain Analysis 3.4. Drivers 3.5. Restraints 3.6. Trends 4. Global Connected Drug Delivery Devices Market Revenue Forecast till 2025 5. Global Connected Drug Delivery Devices Market by Product Type Revenue Forecast till 2025 5.1. Inhalation Devices 5.2. Solid Dosage Forms Devices 5.3. Injectable Devices 5.3.1. Handheld Injectable Devices 5.3.2. Wearable Injectable Devices 6. Global Connected Drug Delivery Devices Market by Technology Revenue Forecast till 2025 6.1. Bluetooth 6.2. Near Field Communication 6.3. Others 7. Global Connected Drug Delivery Devices Market by End User Revenue Forecast till 2025 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Homecare Settings 8. Global Connected Drug Delivery Devices Market by Geography Revenue Forecast till 2025

7. 8.1. North America Connected Drug Delivery Devices Market Revenue Forecast till 2025 8.1.1. North America Connected Drug Delivery Devices Market by Product Type (Option 1: 25% customization) 8.1.1.1. Inhalation Devices 8.1.1.2. Solid Dosage Forms Devices 8.1.1.3. Injectable Devices 8.1.1.3.1. Handheld Injectable Devices 8.1.1.3.2. Wearable Injectable Devices 8.1.2. North America Connected Drug Delivery Devices Market by Technology 8.1.2.1. Bluetooth 8.1.2.2. Near Field Communication 8.1.2.3. Others 8.1.3. North America Connected Drug Delivery Devices Market by End User 8.1.3.1. Hospitals 8.1.3.2. Ambulatory Surgical Centers 8.1.3.3. Homecare Settings 8.2. Europe Connected Drug Delivery Devices Market Revenue Forecast till 2025 8.2.1. Europe Connected Drug Delivery Devices Market by Product Type (Option 2: 25% customization) 8.2.1.1. Inhalation Devices 8.2.1.2. Solid Dosage Forms Devices 8.2.1.3. Injectable Devices 8.2.1.3.1. Handheld Injectable Devices 8.2.1.3.2. Wearable Injectable Devices 8.2.2. Europe Connected Drug Delivery Devices Market by Technology 8.2.2.1. Bluetooth 8.2.2.2. Near Field Communication

8. 8.2.2.3. Others 8.2.3. Europe Connected Drug Delivery Devices Market by End User 8.2.3.1. Hospitals 8.2.3.2. Ambulatory Surgical Centers 8.2.3.3. Homecare Settings 8.3. Asia-Pacific Connected Drug Delivery Devices Market Revenue Forecast till 2025 8.3.1. Asia-Pacific Connected Drug Delivery Devices Market by Product Type (Option 3: 25% customization) 8.3.1.1. Inhalation Devices 8.3.1.2. Solid Dosage Forms Devices 8.3.1.3. Injectable Devices 8.3.1.3.1. Handheld Injectable Devices 8.3.1.3.2. Wearable Injectable Devices 8.3.2. Asia-Pacific Connected Drug Delivery Devices Market by Technology 8.3.2.1. Bluetooth 8.3.2.2. Near Field Communication 8.3.2.3. Others 8.3.3. Asia-Pacific Connected Drug Delivery Devices Market by End User 8.3.3.1. Hospitals 8.3.3.2. Ambulatory Surgical Centers 8.3.3.3. Homecare Settings 8.4. Rest of the World Connected Drug Delivery Devices Market Revenue Forecast till 2025 8.4.1. Rest of the World Connected Drug Delivery Devices Market by Product Type (Option 4: 25% customization) 8.4.1.1. Inhalation Devices 8.4.1.2. Solid Dosage Forms Devices 8.4.1.3. Injectable Devices 8.4.1.3.1. Handheld Injectable Devices

9. 8.4.1.3.2. Wearable Injectable Devices 8.4.2. Rest of the World Connected Drug Delivery Devices Market by Technology 8.4.2.1. Bluetooth 8.4.2.2. Near Field Communication 8.4.2.3. Others 8.4.3. Rest of the World Connected Drug Delivery Devices Market by End User 8.4.3.1. Hospitals 8.4.3.2. Ambulatory Surgical Centers 8.4.3.3. Homecare Settings 9. Competitive Landscape 9.1. Porter 5 Analysis 9.2. Major players and their key strategies 9.3. Company Share Analysis 10. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice) 10.1. Phillips-Medisize 10.1.1. Company Overview 10.1.2. Financials 10.1.3. Recent Developments 10.2. West Pharmaceutical Service 10.2.1. Company Overview 10.2.2. Financials 10.2.3. Recent Developments 10.3. Biocorp Production SA 10.3.1. Company Overview 10.3.2. Financials 10.3.3. Recent Developments 10.4. Aterica

10. 10.4.1. Company Overview 10.4.2. Financials 10.4.3. Recent Developments 10.5. Unilife Corporation 10.5.1. Company Overview 10.5.2. Financials 10.5.3. Recent Developments 10.6. Panasonic 10.6.1. Company Overview 10.6.2. Financials 10.6.3. Recent Developments 10.7. Propeller Health 10.7.1. Company Overview 10.7.2. Financials 10.7.3. Recent Developments 10.8. Qualcomm Technologies 10.8.1. Company Overview 10.8.2. Financials 10.8.3. Recent Developments 10.9. Bayer AG 10.9.1. Company Overview 10.9.2. Financials 10.9.3. Recent Developments 10.10. 3M Company 10.10.1. Company Overview 10.10.2. Financials 10.10.3. Recent Developments 11. About GMI Research Buy Report : https://tinyurl.com/y9e3ntsh About US GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment

11. professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link: https://www.gmiresearch.com/productservices/marketcompetitiveintelligence. html Our Company Profile Solution Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients. We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html

12. Contact – Sarah Nash Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland U.S Office +1 860 881 2270 Europe Office +353 1 442 8820 Email: sales@gmiresearch.com